Transcranial Pulse Stimulation
TPS-THERAPY
The pioneering outpatient treatment option for neurodegenerative diseases
Transcranial Pulse Stimulation - Innovative Procedure
Transcranial Pulse Stimulation is a new, now scientifically well established procedure, which according to studies is recommended for the treatment of mild to moderate Alzheimer’s dementia. This non-invasive shock wave treatment is a method of regenerative medicine that breaks new ground and represents a forward-looking therapeutic option for the non-drug treatment of neuro-degenerative diseases.
Regenerative medicine with Transcranial Pulse Stimulation
Prof. Dr. med. Musa Citak is one of the leading experts in regenerative medicine in Germany, which also includes the field of neurodegeneration. Due to this specialization, he was among the first physicians from the beginning to both practically apply and scientifically research the therapy option Transcranial Pulse Stimulation for the treatment of Alzheimer’s dementia in several studies.
Transcranial Pulse Stimulation - Practical Experience
In the practices of Prof. Dr. med. Musa Citak, he and his medical team have already treated more than 500 patients with Transcranial Pulse Stimulation since the beginning of 2021, both initially and in follow-up treatments (so-called individual booster treatments). The results and outcomes of shock wave treatment are so encouraging that, in our view, this therapy option could or should soon achieve the status of a standard therapy.
Shock Wave Therapy - Transcranial Pulse Stimulation (TPS) at RTL
RTL reports again about shock wave therapy TPS
On World Alzheimer’s Day, September 21, 2023, RTL has reported in several formats, including the main news “RTL AKTUELL” , about the shock wave therapy Transcranial Pulse Stimulation (TPS) as one of the most advanced and helpful treatment options for Alzheimer’s dementia.
In this article my colleague Prof. Dr. med. Ullrich Wüllner, director of the Neurocenter of the University Hospital Bonn (UBK) and one of his patients were interviewed. Prof. Wüllner also attests that Transcranial Pulse Stimulation (TPS) is an innovative shock wave method that not only stops Alzheimer’s disease, but can also bring about significant improvements in many patients.
I am pleased that TPS, which has long been considered one of the most promising therapeutic options for neurodegenerative diseases in specialist circles and at top international congresses, is also being presented more and more in the media. This is the only way that those affected and their relatives can even learn that we already have therapeutic methods at hand that can stop Alzheimer’s disease and significantly improve patients’ quality of life.
Please click on the following image to view!
Prof. Dr. Musa Citak with TPS on RTL in the news
As an expert in regenerative medicine and a leading user of Transcranial Pulse Stimulation, Prof. Citak was the first physician to be featured on television. On November 22, 2021, RTL showed Prof. Citak with his patient Jochen Vieregge from Hamburg in the news program “RTL AKTUELL” as well as in other formats.
Today, in March 2023, that is 1 ½ years later, it is interesting to know: Alzheimer’s patient Jochen Vieregge continues to do as well as shown in the RTL report thanks to Transcranial Pulse Stimulation!
We will soon ask Jochen Vieregge and his wife for an interview again, so that the couple can personally report on the positive results of TPS and the resulting significant increase in quality of life for the benefit of other sufferers.
Please click on the following image to view!
March 2023: TOP NEWS on Transcranial Pulse Stimulation
TPS as a treatment option of Long-Covid, Post-Covid and Neuro-Covid, respectively.
According to new studies, at least ten percent of all SARS-COV-2 infected people worldwide are struggling with the late effects of a corona infection. In Germany alone, it is assumed that around one million people are affected.
If the symptoms, of which the World Health Organization (WHO) has now catalogued around 400 individual symptoms, persist for longer than 12 weeks after the COVID infection, they are referred to as post-Covid.
Since around 80% of these patients suffer from neurological symptoms such as chronic fatigue (CFS syndrome), neurocognitive disorders (e.g. concentration, word-finding and memory disorders), loss of taste and smell, severe physical weakness and even the inability to lead a normal life and work, this special form of post-Covid has been given its own name: Neuro-Covid.
Diagnosis and treatment options for post-covid and neuro-covid to date in the experimental stage.
There are still no medical guidelines or binding treatment parameters for these new clinical pictures. Thus, all current therapeutic measures are in the experimental stage or in the stage of so-called curative trials – be they medicinal or physical.
Transcranial Pulse Stimulation shows up to 95% treatment success in healing trials.
We physicians working with TPS have also thoughtfully addressed the post-covid/neuro-covid issue out of social necessity. Observational studies have also been underway for several months, the results of which are expected to be published before the end of 2023.
It is a fact that so far about 200 post-Covid patients have been treated with TPS with a 95% success rate! This means that the vast majority of patients can be quickly and efficiently relieved of their symptoms with TPS as a core treatment module. Side effects or adverse effects have not been observed to date.
TPS in post-covid and neuro-covid: support of neuroregeneration by shock waves.
Transcranial Pulse Stimulation thus also represents a first remarkable stage victory from the field of modern regenerative medicine in the post-covid and neuro-covid sectors.
Even though TPS is currently gaining significant expertise in a rapid time course anyway due to an ever increasing number of international scientific research and study activities, we are not yet able to serve with study publications on post-covid or neuro-covid; however, based on the postulated efficacy parameters of this shock wave therapy, we are not surprised by the successes in these new diseases.
As an innovative component of an outpatient and for the patient:inside pleasant, non-invasive procedure for treatment, my teams and I now offer Transcranial Pulse Stimulation at all our locations in Germany for Post-Covid and Neuro-Covid patient:inside.
What the Transcranial Pulse Stimulation is, what distinguishes it, which possibilities it can offer (or can not offer!) and which extensive, individual experiences we could collect together with our Patient:in on the basis of the Transcranial Pulse Stimulation also in the long-term course as almost worldwide first practical users of this trend-setting development, you will find described on this website as far as possible.
Gladly my teams at different practice locations and I are at your disposal for all further information.
Your Prof. Dr. med. Musa Citak
Outpatient
Transcranial Pulse Stimulation (TPS) is a non-invasive, safe and outpatient treatment method that is very well tolerated. A TPS session takes only about 30 minutes in total and patients are not restricted in their daily life in any way before and after the treatment.
Safe
The patient sits relaxed in a treatment chair during therapy and can move freely at any time. The shock waves of the TPS have a targeted effect exclusively on the brain. Shaving the hair is not necessary, only a gel is applied to the head.
Soft
Low-energy shock wave pulses are hardly noticeable; you only hear the gentle click when the waves are delivered. In very rare cases, marginal side effects occur, such as a temporary mild headache, which quickly fades.
Transcranial Pulse Stimulation does not prevent degeneration, but it stimulates regeneration as the first treatment method. This is already a great progress, because: If we could stop any degeneration in advance, we would achieve eternal youth. But we are not there yet.
Prof. Musa Citak, M.D.
Below you can see our current TPS locations where Prof. Musa Citak, MD and his teams offer Transcranial Pulse Stimulation. For all locations, please feel free to contact the team at our Hamburg headquarters for questions, consultations, and appointments at info@tps-nord.de or by phone at +49-(0)40-228 546 166
“With Transcranial Pulse Stimulation, my team and I have so far been able to provide meaningful support to over 700 patients and thus also their relatives. We are particularly pleased that after two years of use of TPS, we also see in our own practices that the therapy is actually effective in the long term.”
Prof. Musa Citak, M.D.